New York, USA – July 30, 2020 – As a leading supplier in the biopharmaceutical field, Creative Biostructure has built an advanced COVID-19 discovery platform with its expertise in structural biology that provides basic structure-based research, antiviral drug discovery, and vaccine development to help combat SARS-CoV-2 outbreaks.
The coronavirus COVID-19 is affecting 213 countries and territories around the world and 2 international conveyances. Up to now, 16,652,674 coronavirus cases have been detected and 656,686 deaths have been caused. As the fight against COVID-19 is still tough, Creative Biostructure has established a first-class discovery platform that targets SARS-CoV-2 to offer services (including but not limiting to) for structure/function study, vaccine development and novel drug discovery.
Service offered by Creative Biostructure include:
Metagenomic Analysis of Coronavirus, advanced genome mining for coronavirus, protein sequence analysis, protein structure prediction, protein homology modeling, protein evolution analysis, protein-protein interaction network analysis
Coronavirus-like Particle identification and characterization
Single particle cryo-em for coronavirus-like particle, cryo-electron tomography for coronavirus-like particle, negative staining electron microscopy for coronavirus-like particle, ultra-thin section electron microscopy for coronavirus-like particle, scanning electron microscopy for coronavirus-like particle, super-resolution microscopy for coronavirus-like particle
Protein structure determination
Protein expression and purification, x-ray crystallography services, protein nmr spectroscopy services, protein structure analysis using negative stain em, protein structure analysis using single particle cryo-em, protein structure analysis using cryo-et
Protein interaction analysis
Antiviral drug discovery
Vaccine development services
Moreover, Creative Biostructure provides comprehensive basic research and preclinical research solutions for Middle East respiratory syndrome (MERS) and other coronavirus infections.
“We hope to work with experts from academia, the biotechnology industry, and the pharmaceutical industry to address the ongoing and future human coronavirus outbreaks,” commented Joanna, the official speaker from Creative Biostructure.
To get a whole view of the coronavirus-related services provided by Creative Biostructure, you can visit https://www.creative-biostructure.com/coronavirus.